Patents by Inventor Pierre-Olivier Girodet

Pierre-Olivier Girodet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW COMPOSITIONS AND METHODS OF TREATING COVID-19 DISEASE
    Publication number: 20230157994
    Abstract: A method of treating COVID-19 in a patient. The patient may be in moderate to advanced stages of COVID-19 infection. The method includes administering to the patient a therapeutically effective amount of at least one antagonist or inhibitor of chemokine receptor CXCR4. The at least one antagonist or inhibitor of chemokine receptor CXCR4 is distinct from hydroxychloroquine.
    Type: Application
    Filed: May 5, 2021
    Publication date: May 25, 2023
    Applicants: 4LIVING BIOTECH, UNIVERSITE DE BORDEAUX, CENTRE HOSPITALIER DE BORDEAUX, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM, INSTITUT PASTEUR DE LILLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DE LILLE
    Inventors: Patrick BERGER, Isabelle DUPIN, Renaud PREVEL, Chloé JAMES, Pierre-Olivier GIRODET, Keren BISMUTH, Revital RATTENBACH, Jérôme BRETON, Francois TROTTEIN, Valentin SENCIO
  • Methods of treating and/or preventing chronic obstructive pulmonary disease
    Patent number: 10813911
    Abstract: The present invention relates to a novel composition or method of use for the treatment and/or the prevention of chronic obstructive pulmonary disease (COPD) and acute exacerbations of chronic obstructive pulmonary disease (AECOPDs).
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: October 27, 2020
    Inventors: Patrick Berger, Isabelle Dupin, Pierre-Olivier Girodet
  • NEW COMPOSITIONS AND METHODS OF TREATING AND/OR PREVENTING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Publication number: 20180271831
    Abstract: The present invention relates to a novel composition or method of use for the treatment and/or the prevention of chronic obstructive pulmonary disease (COPD) and acute exacerbations of chronic obstructive pulmonary disease (AECOPDs).
    Type: Application
    Filed: January 28, 2016
    Publication date: September 27, 2018
    Inventors: Patrick BERGER, Isabelle DUPIN, Pierre-Olivier GIRODET
  • BRONCHIAL SMOOTH MUSCLE REMODELING INVOLVES CALCIUM-DEPENDENT ENHANCED MITOCHONDRIAL BIOGENESIS IN ASTHMA
    Publication number: 20090318413
    Abstract: The present invention thus provides a method of inhibiting bronchial smooth muscle remodeling in asthma, comprising the step of administering to a subject having asthma an agent that inhibits calcium-dependent mitochondrial biogenesis.
    Type: Application
    Filed: June 18, 2009
    Publication date: December 24, 2009
    Applicant: UNIVERSITE VICTOR SEGALEN BORDEAUX 2
    Inventors: Patrick BERGER, Thomas Trian, Rodrigue Rossignol, Roger Marthan, J. Manuel Tunon de Lara, Pierre-Olivier Girodet